-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Genting Xinyao (01952.HK) issued an announcement. China's National Drug Administration (NMPA) has approved the new drug marketing license application for Starbital® (etripamil nasal spray) to treat acute episodes of paroxysmal supraventricular tachycardia (PSVT) in adults, which reverted to sinus rhythm.

Zhitongcaijing·09/03/2026 12:17:12
Listen to the news
Zhitong Finance App News, Genting Xinyao (01952.HK) issued an announcement. China's National Drug Administration (NMPA) has approved the new drug marketing license application for Starbital® (etripamil nasal spray) to treat acute episodes of paroxysmal supraventricular tachycardia (PSVT) in adults, which reverted to sinus rhythm.